Chemoinformaics analysis of exiguaflavanone A
| Molecular Weight | 424.493 | nRot | 6 |
| Heavy Atom Molecular Weight | 396.269 | nRig | 20 |
| Exact Molecular Weight | 424.189 | nRing | 3 |
| Solubility: LogS | -3.496 | nHRing | 1 |
| Solubility: LogP | 5.807 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 65.2322 |
| nHD | 4 | BPOL | 30.6938 |
| QED | 0.468 |
| Synth | 4.005 |
| Natural Product Likeliness | 2.393 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.173 |
| Pgp-sub | 0.002 |
| HIA | 0.017 |
| CACO-2 | -4.837 |
| MDCK | 0.0000128 |
| BBB | 0.005 |
| PPB | 0.988475 |
| VDSS | 0.397 |
| FU | 0.0117214 |
| CYP1A2-inh | 0.555 |
| CYP1A2-sub | 0.831 |
| CYP2c19-inh | 0.826 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.876 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.904 |
| CYP2d6-sub | 0.466 |
| CYP3a4-inh | 0.264 |
| CYP3a4-sub | 0.205 |
| CL | 13.262 |
| T12 | 0.252 |
| hERG | 0.032 |
| Ames | 0.053 |
| ROA | 0.747 |
| SkinSen | 0.928 |
| Carcinogencity | 0.312 |
| EI | 0.907 |
| Respiratory | 0.775 |
| NR-Aromatase | 0.723 |
| Antiviral | Yes |
| Prediction | 0.720678 |